Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  fluorine F 18 fluoroethylcholine
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-6 of 6 for your search:
Start Over
Ga-68-NODAGA-MJ9 Compared to F-18-FCH PET/CT for Prostate Cancer Patients
Phase: Phase II, Phase I
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 402/12, NCT02111954
[18F] Fluorocholine FCH Positron Emission Tomography (PET)/Computed Tomography (CT) for Detection of Prostate Cancer Lymph Nodes Metastases
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: PROPET, Project nr. 104., NCT00670527
Impact of F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 90 and under
Sponsor: Other
Protocol IDs: 178/08, NCT00963755
Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate Cancer
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: P090105, 2011-A01041-40, NCT01501630
Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 007697, NCT01836484
18F-FluoroethylCholine Positron Emission Tomography: a Promising Diagnostic Tool for Hepatocellular Carcinoma
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: FECH-PET-2014, NCT02238769
Start Over